GILD is a stock I've traded off and on to unremarkable results. In the world of Biotech, it's a low growth value stock and speaking personally, as long as it…
I am keeping an eye on the Biotech sector as IBB starts to make a move. I'm not watching it to buy it but rather, because I've already bought it…
Though not positively aligned with a rising long-term interest rate environment, maybe BioPharma has anticipated the bump in yields and bottomed. We'll see. But one stock we've tracked in the…
As you surely know, they don't all work this way. But trading GILD has been like clockwork for me since buying the lows in June. Buy the washout and positive…
You could say GILD replaced ABBV after I took its profit and now ABBV is back after I took GILD's profit. It may sound slick, but it is really just…
It's been a great run off the June bottom and now all Biotech profits are booked. I'll hold general Healthcare for now, with all individual stocks in the books (except…
As to the post's title, I have no idea. What I do know is that a nice profit is in the books on a suddenly overbought GILD off of Tuesday's…
Yesterday we got the surge and then the ease into the close. Today? Err... The weekly now targets 350, barring a harsh reversal over the next 2 days. GILD was…
Gilead (GILD) has hit the target laid out in this NFTRH+ post from April. As I often do, I sold below the target but for the record, it's a very…
Personally, I am leaning slightly toward bearish on the stock market, but the Biotech sector has been going to its own beat. Taken in a vacuum, Gilead has an interesting…
[edit] post unlocked to give public readers an idea of how NFTRH manages the entirety of the market (not just special interests like precious metals, tech, semiconductors, etc.) every step…